Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Mar 21, 2023

SELL
$160.2 - $179.79 $223,959 - $251,346
-1,398 Closed
0 $0
Q3 2022

Mar 21, 2023

SELL
$161.33 - $179.52 $79,858 - $88,862
-495 Reduced 26.15%
1,398 $228 Million
Q2 2022

Mar 21, 2023

SELL
$168.19 - $186.01 $250,266 - $276,782
-1,488 Reduced 44.01%
1,893 $336 Million
Q3 2021

Dec 30, 2021

SELL
$161.5 - $179.47 $11,143 - $12,383
-69 Reduced 2.0%
3,381 $546,000
Q1 2021

Dec 30, 2021

SELL
$153.07 - $170.48 $7,194 - $8,012
-47 Reduced 1.34%
3,450 $567,000
Q4 2020

Dec 30, 2021

SELL
$137.11 - $157.38 $4,250 - $4,878
-31 Reduced 0.88%
3,497 $550,000
Q3 2020

Dec 07, 2020

SELL
$140.38 - $153.83 $3,790 - $4,153
-27 Reduced 0.76%
3,528 $525,000
Q2 2020

Dec 07, 2020

BUY
$128.81 - $155.51 $13,525 - $16,328
105 Added 3.04%
3,555 $500,000
Q1 2018

May 21, 2018

BUY
$125.1 - $148.14 $431,595 - $511,082
3,450 New
3,450 $442,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Cabot Wellington, LLC Portfolio

Follow Cabot Wellington, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cabot Wellington, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cabot Wellington, LLC with notifications on news.